The role of serum level of interleukin-6 in severity of pulmonary complications of sulfur mustard injuries

Iranian Journal of Medical Sciences

Volumn 39, Issue 4, 2014, Pages 382-386

  Shohrati, Majid ^a   Harandi, Ali Amini ^a   Najafian, Bita ^a   Saburi, Amin ^a   Ghanei, Mostafa ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bronchiolitis; Cytokines; Interleukin 6; Mustard gas

Indexed keywords

INTERLEUKIN 6; MUSTARD GAS;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHIOLITIS; BRONCHIOLITIS OBLITERANS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; HUMAN; LUNG DISEASE; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PHYSICAL EXAMINATION; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; YOUNG ADULT;

EID: 84904022573     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abul Abbas K, Lichtman AH, Pilla S. Cellular and Molecular Immunology. 7th ed. Philadelphia, PA: Elsevier Saunders; 2007.
2. Wedzicha JA, Seemungal TA, MacCallum PK, Paul EA, Donaldson GC, Bhowmik A, et al. Acute Exacerbation of Chronic obstructive pulmonary Disease Are Accompanied by Elevations of plasma fbrinogen and Serum IL6 levels. Thromb Haemost. 2000;84:210-215. PubMed PMID: 10959691.
3. Bucchioni E, Kharitonov SA, Allegra L, Barnes PJ. High levels of interleukin 6 in the exhaled breath condensate of patients with COPD. Respir Med. 2003;97:1299-1302. doi: 10.1016/j. rmed.2003.07.008. PubMed PMID: 14682411.
4. Song SH, Kim CH, Kwon SS, Kim YK, Kim KH, Moon HS, et al. Nuclear Factor-kappa B(NF-kappa B) Activity and Levels of IL-6, IL-8 and TNF-alpha in Induced Sputum in the Exacerbation and Recovery of COPD Patients. Tuberc Respir Dis. 2005;58:152-59. Korean.
5. Robson-Ansley PJ, de Milander L, Collins M, Noakes TD. Acute interleukin-6 administration impairs athletic performance in healthy, trained male runners. Can J Appl Physiol. 2004;29:411-418. doi: 10.1139/h04-026. PubMed PMID: 15317982.
6. Casadevall C, Coronell C, Ramírez-Sarmiento AL, Martínez-Llorens J, Barreiro E, Orozco-Levi M, et al. Upregulation of pro-infammatory cytokines in the intercostal muscles of COPD patients. Eur Respir J. 2007;30:701-707. doi: 10.1183/09031936.00152005. PubMed PMID: 17626109.
7. Kim MC, Jung J, Jung JH, Kim HR, Yang SH, Jeong ET, et al. The Comparison of the effect of cigarette and stop smoking- aiding cigarette on Release of IL6 from Bronchial Epithelial Cell. Tuberc Repir Dis. 2005;59:530-535. Korean.
8. Pang B, Wang C, Weng X, Tang X, Zhang H, Niu S, et al. Beta-carotene protects rats against bronchitis induced by cigarette smoking. Chin Med J (Engl). 2003;116:514-516. PubMed PMID: 12875713.
9. Neveu WA, Allard JL, Raymond DM, Bourassa LM, Burns SM, Bunn JY, et al. Elevation of IL-6 in the allergic asthmatic airway is independent of infammation but associates with loss of central airway function. Respir Res. 2010;11:28. doi: 10.1186/1465-9921-11-28. PubMed PMID: 20205953; PubMed Central PMCID: PMC2842243.
10. Rincon M, Irvin CG. Role of IL-6 in asthma and other infammatory pulmonary diseases. Int J Biol Sci. 2012;8:1281-1290. doi: 10.7150/ ijbs.4874. PubMed PMID: 23136556; PubMed Central PMCID: PMC3491451.
11. Doganci A, Sauer K, Karwot R, Finotto S. Pathological role of IL-6 in the experimental allergic bronchial asthma in mice. Clin Rev Allergy Immunol. 2005;28:257-270. doi: 10.1385/CRIAI:28:3:257. PubMed PMID: 16129910.
12. Lordan JL, Bucchieri F, Richter A, Konstantinidis A, Holloway JW, Thornber M, et al. Cooperative effects of Th2 cytokines and allergen on normal and asthmatic bronchial epithelial cells. J Immunol. 2002;169:407-414. PubMed PMID: 12077271.
13. Quay JL, Reed W, Samet J, Devlin RB. Air pollution Particles induces IL6 gene expression in human airway epithelial cells via NF-KB activation. Am J Respir Cell Mol Biol. 1998;19:98-106. PubMed PMID: 9651185.
14. Ghanei M, Mokhtari M, Mohammad MM, Aslani J. Bronchiolitis obliterans following exposure to sulfur Mustard: Chest high resolution computed tomography. Eur J Radiol. 2004;52:164-169. doi: 10.1016/j. ejrad.2004.03.018. PubMed PMID: 15489074.
15. Saber H, Saburi A, Ghanei M. Clinical and paraclinical guidelines for management of sulfur mustard induced bronchiolitis obliterans; from bench to bedside. Inhal Toxicol. 2012;24:900-906. doi: 10.3109/08958378.2012.725783. PubMed PMID: 23121299.
16. Ghabili K, Agutter PS, Ghanei M, Ansarin K, Shoja MM. Mustard gas toxicity: the acute and chronic pathological effects. J Appl Toxicol. 2010;30:627-643. PubMed PMID: 20836142.
17. Emad A, Rezaian GR. The diversity of the effects of sulfur mustard gas in halation on respiratory system 10 years after a single, heavy exposure: analysis of 197 cases. Chest. 1997;112:734-738. PubMed PMID: 9315808.
18. Emad A, Rezaian GR. Immunoglobulins and cellular constituents of the BAL Fluid of patients with sulfur mustard gas- induced pulmonary fbrosis. Chest. 1999;115:1346-1351. PubMed PMID: 10334151.
19. Thomason JW, Rice TW, Milstone AP. Bronchiolitis obliterans in a survivor of achemical weapons attack. JAMA. 2003;290:598-599. PubMed PMID: 12902361.
20. Laohaburana kit P, Chan A, Allen RP. Bronchiolitis obliterans. Clin Rev Allergy Immunol. 2003;25:259-274. PubMed PMID: 14716071.
21. Standardization of Spirometry, 1994 Update. American Thoracic Society. American Thoracic Society. Am J Respir Crit Care Med. 1995;152:1107-1136. PubMed PMID: 7663792.
22. Ahmadi K, Solgue G. Cytokine pattern in sera and broncho-alveolar lavage six months after single exposure to sulfur mustard. Medical Journal of the Islamic Republic of Iran. 2006;20:52-55.
23. Attaran D, Lari SM, Towhidi M, Marallu HG, Ayatollahi H, Khajehdaluee M, et al. Interleukin-6 and airfow limitation in chemical warfare patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2010;5:335-340. PubMed PMID: 21037957.
24. Pourfarzam S, Ghazanfari T, Yaraee R, Ghasemi H, Hassan ZM, Faghihzadeh S, et al. Serum levels of IL-8 and IL-6 in the long term pulmonary complications induced by sulfur mustard: Sardasht-Iran Cohort Study. Int Immunopharmacol. 2009;9:1482-1488. PubMed PMID: 19748599.
25. Saburi A, Ghanei M. Comments on "Sulfur Mustard and Respiratory Diseases," Tang & Loke (2012) and a prepared integrated mechanism for chronic pulmonary disease from exposure to sulfur mustard. Crit Rev Toxicol. 2013;43:275-276. doi: 10.3109/10408444.2013.764842. PubMed PMID: 23387376.
26. Saburi A, Shohrati M, Karbasi-Afshar R. Immune-based pathogenesis of sulfur mustard; much still need to be done! Iran J Allergy Asthma Immunol. 2012;11:349-350. doi: 011.04/ijaai.349350. PubMed PMID: 23264414.